Cargando…
A Predictive Risk Score to Diagnose Adrenal Insufficiency in Outpatients: A 7 Year Retrospective Cohort Study
Background: The diagnosis of adrenal insufficiency (AI) requires dynamic tests which may not be available in some institutions. This study aimed to develop a predictive risk score to help diagnose AI in outpatients with indeterminate serum cortisol levels. Methods: Five hundred and seven patients wi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998205/ https://www.ncbi.nlm.nih.gov/pubmed/33801854 http://dx.doi.org/10.3390/medicines8030013 |
_version_ | 1783670498215854080 |
---|---|
author | Manosroi, Worapaka Pipanmekaporn, Tanyong Khorana, Jiraporn Atthakomol, Pichitchai Phimphilai, Mattabhorn |
author_facet | Manosroi, Worapaka Pipanmekaporn, Tanyong Khorana, Jiraporn Atthakomol, Pichitchai Phimphilai, Mattabhorn |
author_sort | Manosroi, Worapaka |
collection | PubMed |
description | Background: The diagnosis of adrenal insufficiency (AI) requires dynamic tests which may not be available in some institutions. This study aimed to develop a predictive risk score to help diagnose AI in outpatients with indeterminate serum cortisol levels. Methods: Five hundred and seven patients with intermediate serum cortisol levels (3–17.9 µg/dL) who had undergone ACTH (adrenocorticotropin) stimulation tests were included in the study. A predictive risk score was created using significant predictive factors identified by multivariable analysis using Poisson regression clustered by ACTH dose. Results: The seven predictive factors used in the development of a predictive model with their assigned scores are as follows: chronic kidney disease (9.0), Cushingoid appearance in exogenous steroid use (12.0), nausea and/or vomiting (6.0), fatigue (2.0), basal cortisol <9 µg/dL (12.5), cholesterol <150 mg/dL (2.5) and sodium <135 mEq/L (1.0). Predictive risk scores range from 0–50.0. A high risk level (scores of 19.5–50.0) indicates a higher possibility of having AI (positive likelihood ratio (LR+) = 11.75), while a low risk level (scores of <19.0) indicates a lower chance of having AI (LR+ = 0.09). The predictive performance of the scoring system was 0.82 based on the area under the curve. Conclusions: This predictive risk score can help to determine the probability of AI and can be used as a guide to determine which patients need treatment for AI and which require dynamic tests to confirm AI. |
format | Online Article Text |
id | pubmed-7998205 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79982052021-03-28 A Predictive Risk Score to Diagnose Adrenal Insufficiency in Outpatients: A 7 Year Retrospective Cohort Study Manosroi, Worapaka Pipanmekaporn, Tanyong Khorana, Jiraporn Atthakomol, Pichitchai Phimphilai, Mattabhorn Medicines (Basel) Article Background: The diagnosis of adrenal insufficiency (AI) requires dynamic tests which may not be available in some institutions. This study aimed to develop a predictive risk score to help diagnose AI in outpatients with indeterminate serum cortisol levels. Methods: Five hundred and seven patients with intermediate serum cortisol levels (3–17.9 µg/dL) who had undergone ACTH (adrenocorticotropin) stimulation tests were included in the study. A predictive risk score was created using significant predictive factors identified by multivariable analysis using Poisson regression clustered by ACTH dose. Results: The seven predictive factors used in the development of a predictive model with their assigned scores are as follows: chronic kidney disease (9.0), Cushingoid appearance in exogenous steroid use (12.0), nausea and/or vomiting (6.0), fatigue (2.0), basal cortisol <9 µg/dL (12.5), cholesterol <150 mg/dL (2.5) and sodium <135 mEq/L (1.0). Predictive risk scores range from 0–50.0. A high risk level (scores of 19.5–50.0) indicates a higher possibility of having AI (positive likelihood ratio (LR+) = 11.75), while a low risk level (scores of <19.0) indicates a lower chance of having AI (LR+ = 0.09). The predictive performance of the scoring system was 0.82 based on the area under the curve. Conclusions: This predictive risk score can help to determine the probability of AI and can be used as a guide to determine which patients need treatment for AI and which require dynamic tests to confirm AI. MDPI 2021-03-10 /pmc/articles/PMC7998205/ /pubmed/33801854 http://dx.doi.org/10.3390/medicines8030013 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Manosroi, Worapaka Pipanmekaporn, Tanyong Khorana, Jiraporn Atthakomol, Pichitchai Phimphilai, Mattabhorn A Predictive Risk Score to Diagnose Adrenal Insufficiency in Outpatients: A 7 Year Retrospective Cohort Study |
title | A Predictive Risk Score to Diagnose Adrenal Insufficiency in Outpatients: A 7 Year Retrospective Cohort Study |
title_full | A Predictive Risk Score to Diagnose Adrenal Insufficiency in Outpatients: A 7 Year Retrospective Cohort Study |
title_fullStr | A Predictive Risk Score to Diagnose Adrenal Insufficiency in Outpatients: A 7 Year Retrospective Cohort Study |
title_full_unstemmed | A Predictive Risk Score to Diagnose Adrenal Insufficiency in Outpatients: A 7 Year Retrospective Cohort Study |
title_short | A Predictive Risk Score to Diagnose Adrenal Insufficiency in Outpatients: A 7 Year Retrospective Cohort Study |
title_sort | predictive risk score to diagnose adrenal insufficiency in outpatients: a 7 year retrospective cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998205/ https://www.ncbi.nlm.nih.gov/pubmed/33801854 http://dx.doi.org/10.3390/medicines8030013 |
work_keys_str_mv | AT manosroiworapaka apredictiveriskscoretodiagnoseadrenalinsufficiencyinoutpatientsa7yearretrospectivecohortstudy AT pipanmekaporntanyong apredictiveriskscoretodiagnoseadrenalinsufficiencyinoutpatientsa7yearretrospectivecohortstudy AT khoranajiraporn apredictiveriskscoretodiagnoseadrenalinsufficiencyinoutpatientsa7yearretrospectivecohortstudy AT atthakomolpichitchai apredictiveriskscoretodiagnoseadrenalinsufficiencyinoutpatientsa7yearretrospectivecohortstudy AT phimphilaimattabhorn apredictiveriskscoretodiagnoseadrenalinsufficiencyinoutpatientsa7yearretrospectivecohortstudy AT manosroiworapaka predictiveriskscoretodiagnoseadrenalinsufficiencyinoutpatientsa7yearretrospectivecohortstudy AT pipanmekaporntanyong predictiveriskscoretodiagnoseadrenalinsufficiencyinoutpatientsa7yearretrospectivecohortstudy AT khoranajiraporn predictiveriskscoretodiagnoseadrenalinsufficiencyinoutpatientsa7yearretrospectivecohortstudy AT atthakomolpichitchai predictiveriskscoretodiagnoseadrenalinsufficiencyinoutpatientsa7yearretrospectivecohortstudy AT phimphilaimattabhorn predictiveriskscoretodiagnoseadrenalinsufficiencyinoutpatientsa7yearretrospectivecohortstudy |